Golden State Warriors star Steph Curry is set to sign a lifetime contract with sportswear brand Under Armour that could be worth over US$1 billion.
Curry and Under Armour teamed for the first time in 2013, and his current reputed US$20 million per year contract with the Baltimore-based company is scheduled to expire in 2024.
In 2020, the four-time NBA champion and Under Armour launched Curry Brand, a dedicated apparel division designed to draw younger consumers.
Only legends Michael Jordan and Lebron James have received lifetime contracts in the NBA; James inked a lifetime contract with Nike in 2015 that is estimated to be worth more than US$1 billion.
Soccer legends Lionel Messi and Cristiano Ronaldo have lifetime deals with Nike and Adidas, respectively. While Messi's contract, inked in 2017, is unknown, Ronaldo's Nike pact, signed in 2016, is reputedly worth US$1 billion.


Champions League final 2025: a battle for glory against a backdrop of money and fashion
Japan Signals Readiness to Intervene as Yen Weakens Toward 160 Per Dollar
Apple Eyes U.S. Formula 1 Broadcast Rights in Major Sports Streaming Push
Trump’s U.S. Open Visit Delays Final, Fans Face Long Security Lines
China's Energy Resilience Shields Economy From Global Oil Shock, Goldman Sachs Says
Luxury Car Sales in the Middle East Take a Hit Amid Iran War
TSMC Japan's Second Fab to Produce 3nm Chips by 2028
CTOC Adds 3,000 Doctors, 500 Hospitals Ahead of Liquidity Push
‘The geezer game’ – a nearly 50-year-old pickup basketball game – reveals its secrets to longevity
Trump to Host UFC Event at White House on His 80th Birthday
Samsung Electronics Eyes Record Q1 Profit Amid AI-Driven Chip Boom
U.S. Plans $115 Million Counter-Drone Investment to Secure FIFA World Cup and Major National Events
Norma Group Posts Revenue Decline in 2025, Eyes Modest Recovery in 2026
Trump Booed at Club World Cup Final, Praises Pele as Soccer’s GOAT
Apple Turns 50: From Garage Startup to AI Crossroads
Eli Lilly and Insilico Medicine Forge $2.75 Billion AI-Driven Drug Discovery Deal
Trump Administration Plans 100% Tariffs on Pharmaceutical Imports 



